CGEN
Compugen Ltd
Stock NASDAQ – Stock Market Prices, News & Analysis
Compugen Ltd focuses on the discovery and development of cancer immunotherapy drugs using computational methods.
Compugen Ltd
CGEN
Compugen Ltd focuses on the discovery and development of cancer immunotherapy drugs using computational methods.
Price history of Compugen Ltd
Price history of Compugen Ltd
Performance & Momentum
Strategic Analysis
Compugen Ltd • 2026
Compugen Ltd positions itself as a biotech company specializing in immuno-oncology, with an approach centered on target discovery and the development of innovative therapies. Its profile relies more on research and the creation of scientific value than on a mature industrial model, making it a specialty stock with significant clinical leverage.
- Clear positioning in an attractive segment of innovative healthcare, with a focus on immuno-oncology
- Significant re-rating potential in the event of clinical success or a strategic partnership
- Favorable stock-price momentum, suggesting renewed market interest in the story
- High dependence on research results and clinical milestones, with significant execution risk
- Fragile long-term performance history, highlighting the stock's structural volatility
Momentum appears strong and clearly upward, with recent acceleration reflecting growing market confidence in the company's scientific profile. The trend is constructive in the short and medium term, but remains typical of a speculative biotech, where share-price performance depends heavily on pipeline progress, clinical data, and potential partnership announcements.
Similar stocks to Compugen Ltd
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
